{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:58:02Z","timestamp":1778158682979,"version":"3.51.4"},"reference-count":6,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>\n                  <jats:bold>Safety alert<\/jats:bold>: Esmya (ulipristal acetate) for symptoms of uterine fibroids: restrictions to use and requirement to check liver function before, during and after treatment.1,2\n<\/jats:p>","DOI":"10.1136\/dtb.2018.11.000033","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T12:21:33Z","timestamp":1539001293000},"page":"127-127","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Ulipristal acetate (Esmya): restrictions on use"],"prefix":"10.1136","volume":"56","member":"239","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"2025082623064294000_56.11.127.1","unstructured":"Medicines and Healthcare products Regulatory Agency, 2018. Esmya (ulipristal acetate) for symptoms of uterine fibroids: restrictions to use and requirement to check liver function before, during and after treatment [online]. Available: https:\/\/www.cas.mhra.gov.uk\/ViewandAcknowledgment\/ViewAlert.aspx?AlertID=102786 [Accessed 29 August 2018]."},{"issue":"1","key":"2025082623064294000_56.11.127.2","first-page":"1","article-title":"Esmya (ulipristal acetate) and risk of serious liver injury: new restrictions to use and requirements for liver function monitoring before, during, and after treatment","volume":"12","author":"Medicines and Healthcare products Regulatory Agency","year":"2018","journal-title":"Drug Safety Update"},{"key":"2025082623064294000_56.11.127.3","unstructured":"European Medicines Agency, 2018. Esmya: new measures to minimise risk of rare but serious liver injury [online]. Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Esmya\/human_referral_prac_000070.jsp&mid=WC0b01ac05805c516f [Accessed 29 August 2018]."},{"issue":"8","key":"2025082623064294000_56.11.127.4","first-page":"2","article-title":"Esmya (ulipristal acetate) for uterine fibroids: do not initiate or re-start treatment; monitor liver function in current and recent users","volume":"11","author":"Medicines and Healthcare products Regulatory Agency","year":"2018","journal-title":"Drug Safety Update"},{"key":"2025082623064294000_56.11.127.5","unstructured":"EMC, 2018. Risk materials [online]. Available: https:\/\/www.medicines.org.uk\/emc\/product\/3951\/rmms [Accessed 29 August 2018]."},{"key":"2025082623064294000_56.11.127.6","unstructured":"NHS Digital, 2018. Prescription Cost Analysis - England, 2017 [online]. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/prescription-cost-analysis\/prescription-cost-analysis-england-2017 [Accessed 29 August 2018]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2018.11.000033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:06:53Z","timestamp":1756274813000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2018.11.000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":6,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,10,24]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/dtb.2018.11.000033"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2018.11.000033","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]}}}